Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Articles

Experts at Xcelience provided commentary on the evolving role of contract services in analytical services and solid/semi-solid development manufacturing.

Outsourcing Perspectives from Xcelience

The quality-by-design principles used to control process variability are equally important to measurement systems because process variability includes contributions from measurement system variability. The authors use real-life examples from drug development projects to outline how an understanding of chromatographic measurement system variability might be achieved.

Using Quality by Design to Develop Robust Chromatographic Methods

Experts from Baxter BioPharma Solutions provided the following commentary on trends in bio/pharmaceutical development outsourcing.

Outsourcing Perspectives from Baxter BioPharma Solutions

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Annual study shows geographic proximity not a factor in CMO selection.

Targeting Different Off-Shore Destinations

John Sandles, Business Analyst for Fujifilm Diosynth Biotechnologies, provided commentary on the evolving role of contract services in biologics drug development and manufacturing.

Outsourcing Perspectives from John Sandles of Fujifilm Diosynth Biotechnologies

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Changing regulations are impacting the identification and monitoring of variable materials in excipients.

Taking Action on Elemental Impurities

Biopharma manufacturers must reduce the risk in their complex supply chains

Acute Need for Supply Chain Transparency

Annual study shows CMO technical expertise is not enough.

Relationship-building at Top of Mind for Clients

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.

Pharma Investments Reflect Key Industry Trends

Developments in chromatography column technology to deliver greater efficiency, speed and inertness benefit the drug development process from discovery to manufacturing and quality control.